A pilot study of Taxotere [docetaxel] combined with Xeloda [capecitabine] in the treatment of metastatic breast cancer.
Phase of Trial: Phase II
Latest Information Update: 13 Feb 2012
At a glance
- Drugs Capecitabine; Docetaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 13 Feb 2012 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
- 13 Feb 2012 Actual patient number (18) added as reported by ClinicalTrials.gov.
- 13 Feb 2012 Actual end date (1 Jan 2006) added as reported by ClinicalTrials.gov.